18 | PolyaminesIBA
06/2022
-
06/2005 |
14 | SpermineIBA
01/2021
-
05/2002 |
13 | Oxidoreductases (Dehydrogenase)IBA
10/2016
-
06/2005 |
12 | AminesIBA
10/2016
-
06/2005 |
8 | AldehydesIBA
09/2014
-
05/2002 |
7 | EnzymesIBA
01/2015
-
06/2005 |
6 | Pharmaceutical PreparationsIBA
06/2022
-
05/2002 |
4 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017
-
08/2016 |
4 | Reactive Oxygen Species (Oxygen Radicals)IBA
10/2016
-
10/2006 |
4 | Proteins (Proteins, Gene)FDA Link
01/2015
-
09/2007 |
4 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2013
-
10/2006 |
3 | Polyamine OxidaseIBA
11/2019
-
03/2014 |
3 | SpermidineIBA
06/2019
-
01/2008 |
2 | Antineoplastic Agents (Antineoplastics)IBA
06/2022
-
05/2002 |
2 | AntioxidantsIBA
01/2022
-
09/2018 |
2 | Caspase 3 (Caspase-3)IBA
01/2021
-
01/2008 |
2 | Nucleic AcidsIBA
01/2021
-
01/2015 |
2 | Therapeutic UsesIBA
11/2020
-
11/2019 |
2 | LigandsIBA
01/2020
-
08/2016 |
2 | Transcription Factors (Transcription Factor)IBA
11/2019
-
01/2019 |
2 | AndrogensIBA
03/2014
-
01/2014 |
2 | PutrescineIBA
01/2014
-
01/2008 |
2 | Biomarkers (Surrogate Marker)IBA
05/2013
-
05/2012 |
2 | MDL 72527IBA
09/2009
-
10/2006 |
1 | bispidineIBA
06/2022 |
1 | Culture MediaIBA
06/2022 |
1 | 1,2-diazabicyclo(3.3.1)nonaneIBA
06/2022 |
1 | Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
05/2022 |
1 | PolyphenolsIBA
01/2022 |
1 | Alkylating AgentsIBA
01/2022 |
1 | CurcuminIBA
07/2021 |
1 | Carrier Proteins (Binding Protein)IBA
01/2021 |
1 | RNA (Ribonucleic Acid)IBA
01/2021 |
1 | Hypoglycemic Agents (Hypoglycemics)IBA
11/2020 |
1 | Co-Repressor ProteinsIBA
11/2020 |
1 | Phenformin (Fenformin)IBA
11/2020 |
1 | BiguanidesIBA
11/2020 |
1 | Cysteine (L-Cysteine)FDA Link
02/2020 |
1 | Ionotropic Glutamate ReceptorsIBA
01/2020 |
1 | Ion Channels (Ion Channel)IBA
01/2020 |
1 | HhAntag691IBA
01/2019 |
1 | MitogensIBA
01/2019 |
1 | NocodazoleIBA
01/2019 |
1 | Phosphotransferases (Kinase)IBA
01/2019 |
1 | 5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA
09/2018 |
1 | Fluorescent Dyes (Fluorescent Probes)IBA
09/2018 |
1 | Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
10/2017 |
1 | Epidermal Growth Factor (EGF)IBA
10/2017 |
1 | Ciliary Neurotrophic Factor (CNTF)IBA
10/2017 |
1 | Nerve Growth Factor (NGF)IBA
10/2017 |
1 | Nerve Growth Factors (Neurotrophins)IBA
10/2017 |
1 | Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2017 |
1 | Biological ProductsIBA
10/2017 |
1 | Growth InhibitorsIBA
10/2017 |
1 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2017 |
1 | Angiogenesis InhibitorsIBA
06/2017 |
1 | Dexamethasone (Maxidex)FDA LinkGeneric
10/2016 |
1 | chromium hexavalent ionIBA
10/2016 |
1 | Oxygen (Dioxygen)IBA
01/2015 |
1 | Chloroquine (Aralen)FDA LinkGeneric
09/2014 |
1 | DNA (Deoxyribonucleic Acid)IBA
03/2014 |
1 | ornithine decarboxylase antizymeIBA
03/2014 |
1 | OligonucleotidesIBA
03/2014 |
1 | Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
03/2014 |
1 | A-Form DNA (A-DNA)IBA
03/2014 |
1 | Pyruvate KinaseIBA
01/2014 |
1 | Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2014 |
1 | Anti-Obesity Agents (Antiobesity Drugs)IBA
01/2014 |
1 | RoscovitineIBA
01/2014 |
1 | Hormones (Hormone)IBA
01/2014 |
1 | Androgen Receptors (Androgen Receptor)IBA
01/2014 |